Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gossmann

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Kidney & Blood Pressure Research|July 4, 2001
Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?J Gossmann, A Radounikli, A Bernemann, et al.
Kidney International|June 26, 2001
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathwayJ Gossmann, R Burkhardt, S Harder, et al.
The American Journal of Pathology|July 1, 1993
Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system diseaseA Vallbracht, J Löhler, J Gossmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trialR Salgo, J Gossmann, H Schöfer, et al.
Nuklearmedizin. Nuclear Medicine|January 6, 2006
Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearanceN Hamscho, A Wilhelm, N Döbert, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteersJ Gossmann, R Burkhardt, S Harder, et al.
Der Urologe. Ausg. A|February 3, 2007
[Quality of kidney procurement in Germany. Ten years experience and 486 renal allografts in a single centre]Wassilios Bentas, M Probst, J Jones, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Kidney & Blood Pressure Research|July 4, 2001
Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?J Gossmann, A Radounikli, A Bernemann, et al.
Kidney International|June 26, 2001
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathwayJ Gossmann, R Burkhardt, S Harder, et al.
The American Journal of Pathology|July 1, 1993
Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system diseaseA Vallbracht, J Löhler, J Gossmann, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 4, 2010
Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trialR Salgo, J Gossmann, H Schöfer, et al.
Nuklearmedizin. Nuclear Medicine|January 6, 2006
Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearanceN Hamscho, A Wilhelm, N Döbert, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteersJ Gossmann, R Burkhardt, S Harder, et al.
Der Urologe. Ausg. A|February 3, 2007
[Quality of kidney procurement in Germany. Ten years experience and 486 renal allografts in a single centre]Wassilios Bentas, M Probst, J Jones, et al.
Pageof 3